Vanda Pharmaceuticals, Inc. (NASDAQ:VNDA)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of clinical-stage drug candidates, with exclusive worldwide commercial rights to three product candidates in clinical development for various central nervous system disorders.

Recs

0
Player Avatar qubit16 (98.06) Submitted: 12/3/2007 9:55:28 PM : Underperform Start Price: $8.56 VNDA Score: +45.53

od

Featured Broker Partners


Advertisement